These pathways included newly identified proteins, such as APOB, SCP2, and CRP, along with well-established AD-related proteins including CLU, APOE or BIN1, that have been identified in genetics studies, supporting that some of these pathways and processes are part of the causal pathway and not only secondary to the disease. This evidence concerns the gene CRP and Alzheimer disease.